Page 138 - MI-2-4

Microbes & Immunity Oxidative toxicity and folate in HIV on DTG-ART

doi: 10.1056/NEJMoa1805230 immunoassay: Basic mechanism and application. Bangladesh
J Nuclear Med. 2018;18(2):171.
10. Assefa N, Abdullahi YY, Abraham A, et al. Consumption of
dietary folate estimates and its implication for reproductive doi: 10.3329/bjnm.v18i2.35240
outcome among women of reproductive age in Kersa: Cross-
sectional survey. BMC Nutr. 2021;7(1):69. 22. Gutteridge JM, Wilkins SC. Copper dependent hydroxyl
radical damage to ascorbic acid; formation of thiobarbituric
doi: 10.1186/s40795-021-00482-w acid reactive products. FEBS Lett. 1982;137:327-330.
11. Jakimiuk A, Piechal A, Wiercińska-Drapało A, Nowaczyk A, doi: 10.1016/0014-5793(82)81330-8
Mirowska-Guzel D. Dolutegravir induces FOLR1 expression
during brain organoid development. Front Mol Neurosci. 23. Buege JA, Aust SD. Microsomal lipid peroxidation. In:
2024;17:1463159. Fleischer S, Packer L, editors. Methods in Enzymology.
Vol. 52. United States: Academic Press; 1978. p. 302-310.
doi: 10.3389/fnmol.2024.1463159
24. Piantadosi CA, Suliman HB. Mitochondrial dysfunction in
12. Alcorn K. Adequate Levels of Folate Protect Against Neural oxidative stress. Free Radic Biol Med. 2017;122:134-146.
Tube Defects When Taking Dolutegravir. NAM aidsmap;
2024. Available from: https://www.aidsmap.com [Last doi: 10.1016/j.freeradbiomed.2018.01.003
accessed on 2025 Sep 25]. 25. Shytaj IL, Norelli S, Chirullo B, Palamara AT. Oxidative stress
13. Quirós Roldán M, Bresciani A, Savoldi A. Dolutegravir and and HIV infection: Role in pathogenesis and therapeutic
folic acid interaction during neural system development: strategies. Expert Rev Anti Infect Ther. 2020;18(5):447-460.
Zebrafish embryo model. Int J Mol Sci. 2024;25(9):4640. doi: 10.1080/14787210.2020.1762438
doi: 10.3390/ijms25094640 26. Reust CE. Common adverse effects of antiretroviral therapy
14. Saint-Lary O, Martin C, Leclerc T. Post-marketing for HIV disease. Am Fam Physician. 2011;83(12):1443-1451.
safety concerns with dolutegravir: A comprehensive 27. Bailey LB, Gregory JF 3 . Folate metabolism and
rd
pharmacovigilance review. Front Pharmacol. requirements. J Nutr. 2015;145(3):593-596.
2025;16:1399821.
doi: 10.3945/jn.114.204009
doi: 10.3389/fphar.2025.1399821
28. Flax VL, Adair LS, Allen LH, et al. Plasma micronutrient
15. Masenga SK, Kabwe LS, Chakulya M, Kirabo A. Mechanisms concentrations are altered by antiretroviral therapy and
of oxidative stress in metabolic syndrome. Int J Mol Sci. lipid-based nutrient supplements in lactating HIV-infected
2023;24(9):7898.
Malawian women. J Nutr. 2015;145(8):1950-1957.
doi: 10.3390/ijms24097898
doi: 10.3945/jn.115.220109
16. Jain RG, Furfine ES, Pedneault L, White AJ, Lenhard JM. 29. Alani A, Vincent O, Adewumi A, et al. Plasma folate
Metabolic complications associated with antiretroviral studies in HIV-positive patients at the Lagos University
therapy. Antiviral Res. 2001;51:151-177.
Teaching Hospital, Nigeria. Indian J Sex Transm Dis AIDS.
doi: 10.1016/S0166-3542(01)00147-7 2010;31(2):99-103.
17. Alfadda AA, Sallam RM. Reactive oxygen species in health doi: 10.4103/0253-7184.74995
and disease. J Biomed Biotechnol. 2012;2012:936486.
30. Barlow-Mosha LN, Ahimbisibwe GM, Chappell E, et al.
doi: 10.1155/2012/936486 Effect of dolutegravir on folate, vitamin B12 and mean
18. De Greef J, Yombi JC, Vincent A, et al. Dolutegravir and corpuscular volume levels among children and adolescents
risk of neuropsychiatric adverse events: A pharmacogenetic with HIV: A sub-study of the ODYSSEY randomized
study. J Infect Dis. 2025;231(6):1425-1429. controlled trial. J Int AIDS Soc. 2023;26(9):e26174.
doi: 10.1093/infdis/jiaf098 doi: 10.1002/jia2.26174
19. Jakimiuk A, Piechal A, Wiercińska-Drapało A, Nowaczyk A, 31. Korencak M, Byrne M, Richter E, et al. Effect of HIV
Mirowska-Guzel D. Central nervous system disorders after infection and antiretroviral therapy on immune cellular
use of dolutegravir: Evidence from preclinical and clinical functions. JCI Insight. 2019;4(12):e126675.
studies. Pharmacol Rep. 2023;75(6):1138-1151. doi: 10.1172/jci.insight.126675
doi: 10.1007/s43440-023-00515-y 32. Oyeyipo IP, Skosana BT, Everson FP, Strijdom H, du
20. National Agency for the Control of AIDS (NACA). National Plessis SS. Highly active antiretroviral therapy alters sperm
HIV/AIDS Indicator and Impact Survey (NAIIS) 2021: parameters and testicular antioxidant status in diet-induced
Technical Report. Abuja, Nigeria: NACA; 2021. obese rats. Toxicol Res. 2018;34(1):41-48.
21. Azim M, Hasan M, Ansari IH, Nasreen F. Chemiluminescence doi: 10.1039/c7tx00205h

Volume 2 Issue 4 (2025) 130 doi: 10.36922/MI025310074